This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Renal Cell; Erlotinib Hydrochloride; Kidney Neoplasms; Leiomyomatosis; Neoplastic Syndromes, Hereditary
|
|
information resource reference
|
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.
|
|
label
|
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.
|